A pioneer in the use of CD8+ T Cells as a therapeutic tool for various Viral Infections, Dr. Otto Yang is a prestigious Physician highly specialized in Cellular Immunology. In addition, he has led multiple scientific research projects that have laid the groundwork for the development of innovative therapies and even vaccines.

In this sense, he has worked in health institutions of international reference such as UCLA Health in California. In this way, his work has been focused on the creation and implementation of modern treatments to manage conditions related to HIV, AIDS or cancer. Thanks to this, he has driven advances in the design of personalized immunological treatments adapted to the specific needs of each patient. As a result, he has managed to optimize the overall well-being of numerous patients in the long term.

Moreover, he has been a key figure in the conduct of clinical trials related to COVID-19. As such, he has conducted a variety of comprehensive analyses to evaluate the effects of therapies such as Remdesivir, Baricitinib and even Monoclonal Antibodies. Such work has been essential to identify the most effective therapeutic options and improve informed clinical decision making on a global scale in the face of the SARS-CoV-2 outbreak.

Throughout its 40-year history, its clinical excellence has been rewarded on several occasions in the form of awards. An example of this is the award he received from the American Association of Immunologists for his CAR-T therapies for the treatment of leukemias. In his strong commitment to advancing healthcare, he has led a wide range of projects that have received more than 30 million dollars in funding. These achievements reflect his strategic leadership in generating cutting-edge solutions that bring tangible value to society.

• Chief of the Division of Infectious Diseases at UCLA Health in California, United States
• Founder and Chief Medical Officer of CDR3 Therapeutics, California
• Director of Scientific Research at AIDS Healthcare Foundation, Los Angeles, Los Angeles

• Research Scientist with over 170 published papers

• Scientific Director of Ozyma, Los Angeles

• HIV Physician at MCI-Cedar Junction, Massachusetts

• Infectious Diseases Internship at Harvard Medical School

• Internal Medicine Residency at Bellevue Hospital, New York

• M.D. from Brown University

• Member of: Board of Directors at California Applied Medicine and Frontida Electronic Health Records Software